Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000026

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 9, 2018
Accepted (ET)
May 16, 2018 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 9, 2018P2,000$0.0359A25,024,389D
Common StockMay 9, 2018P100$0.0357A25,024,489D
Common StockMay 9, 2018P1,000$0.036A25,025,489D
Common StockMay 9, 2018P1,000$0.0387A25,026,489D
Common StockMay 9, 2018P1,000$0.0387A25,027,489D
Common StockMay 9, 2018P1,000$0.0388A25,028,489D
Common StockMay 10, 2018P1,000$0.039A25,029,489D
Common StockMay 10, 2018P1,000$0.039A25,030,489D
Common StockMay 10, 2018P1,000$0.04A25,031,489D
Common StockMay 10, 2018P1,000$0.04A25,032,489D
Common StockMay 10, 2018P1,000$0.04A25,033,489D
Common StockMay 11, 2018P1,000$0.041A25,034,489D
Common StockMay 11, 2018P1,000$0.041A25,035,489D
Common StockMay 11, 2018P1,000$0.041A25,036,489D
Common StockMay 11, 2018P175$0.041A25,036,664D
Common StockMay 11, 2018P1,000$0.0405A25,037,664D
Common StockMay 11, 2018P1,000$0.0417A25,038,664D
Common StockMay 11, 2018P825$0.041A25,039,489D
Common StockMay 11, 2018P1,000$0.041A25,040,489D
Common StockMay 11, 2018P1,000$0.041A25,041,489D
Common StockMay 11, 2018P1,000$0.04A25,042,489D
Common StockMay 14, 2018P1,000$0.0409A25,043,489D
Common StockMay 14, 2018P1,000$0.0408A25,044,489D
Common StockMay 14, 2018P1,000$0.042A25,045,489D
Common StockMay 14, 2018P1,000$0.0428A25,046,489D

Table II — derivative securities

No Table II lines on this filing.